NUR 1141 Pharmacology Study Guide
Uploaded by
mintz81NUR 1141 Pharmacology Study Guide
Uploaded by
mintz81Common questions
Powered by AIHerbal supplements can complement conventional medication by promoting health and managing minor ailments, yet they pose significant risks when used concomitantly due to potential interactions. Supplements such as St. John’s Wort can induce CYP450 enzymes, reducing the efficacy of drugs like oral contraceptives or anticoagulants. Conversely, supplements like ginseng might potentiate the effects of anticoagulants, increasing bleeding risk. Thus, understanding the pharmacokinetics and pharmacodynamics of both supplements and prescribed medications is crucial for safe integration into treatment regimens, avoiding adverse effects and ensuring efficacy .
Beta-2 agonists play a pivotal role in respiratory therapies by targeting beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation. They are primarily used in managing asthma and chronic obstructive pulmonary disease (COPD) to alleviate symptoms such as wheezing, coughing, and breathlessness. The activation of these receptors causes relaxation of bronchial muscles, improving airway patency. Common side effects include tremors, headache, tachycardia, and palpitations due to their systemic adrenergic effects . These adverse effects must be considered, especially in patients with underlying heart conditions.
Conversion factors are critical in safe dose range calculations to ensure accurate dosages are administered, especially in pediatrics where precise dosing is crucial. For instance, weight must be converted from pounds to kilograms (1 lb = 0.454 kg) to use standard dosing formulas based on mg/kg. In cases requiring Body Surface Area (BSA) dosing, formulas like BSA (m²) = sqrt([height (cm) × weight (kg)]/3600) are applied. This ensures doses are tailored to the child's size to avoid under-dosing or overdosing, both of which could lead to ineffective treatment or adverse reactions .
Nonsteroidal anti-inflammatory drugs (NSAIDs) are absorbed well in the gastrointestinal tract with peak plasma levels reached within 2-4 hours. They undergo hepatic metabolism primarily via the cytochrome P450 enzyme system, specifically CYP2C9, with metabolites excreted renally. Factors such as liver function, age, and concurrent medications can significantly alter NSAID metabolism. Their impact on the body systems includes inhibition of cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which alleviates pain and inflammation. However, this can also lead to gastrointestinal mucosal damage, renal impairment, and increased cardiovascular risk, necessitating careful patient evaluation before prescribing .
Understanding drug metabolism is essential for tailoring treatment plans, especially with endocrine medications such as insulin or thyroid hormones. Metabolic factors include hepatic and renal function, genetic variations (e.g., CYP450 polymorphisms), and interactions with concurrent medications. For instance, a patient with hepatic impairment might have altered metabolism of an oral hypoglycemic, necessitating dosage adjustments to avoid hypoglycemia. Similarly, thyroid disorders can affect metabolism rates and efficacy for other concurrent treatments. Thus, comprehensive assessments of these factors enable personalized dosing regimens, optimizing therapeutic outcomes while minimizing adverse effects .
The ethical principles guiding medication administration include autonomy, beneficence, non-maleficence, and justice. Autonomy ensures that patients are fully informed and can make independent decisions regarding their treatment. Beneficence involves healthcare providers acting in the best interests of the patient to maximize beneficial outcomes. Non-maleficence obligates providers to avoid causing harm. Justice requires fair distribution of healthcare resources and impartial treatment . These principles ensure patient safety by promoting informed consent, supporting effective and safe treatment interventions, and advocating for the fair treatment of all patients.
The route of medication administration significantly influences pharmacodynamics, or the effects of the drug on the body, due to differences in absorption rates, onset times, and bioavailability. For instance, intravenous routes provide immediate effects, while oral routes may have delayed onset due to absorption processes. The choice of route also affects patient compliance; oral medications are generally preferred due to ease of administration, while invasive routes like injections might decrease compliance unless necessary for rapid or targeted effect. Balancing route efficiency with patient preferences can optimize treatment adherence and outcomes .
Dosage form and half-life are critical in prescribing antimicrobial drugs for persistent infections. The half-life determines dosing frequency; a longer half-life allows for less frequent dosing, improving compliance. Extended-release formulations can also maintain therapeutic levels over prolonged periods. These considerations ensure sustained antimicrobial exposure, crucial for eradicating persistent infections and reducing resistance development. For example, antimicrobials with short half-lives may require multiple daily doses, risking compliance, while those with long half-lives or in depot forms may maintain effective concentrations with fewer doses or less frequent administration .
Drug schedules categorize medications based on their potential for abuse and medical use, directly affecting medication management. Schedule I drugs have high abuse potential with no accepted medical use (e.g., heroin), while Schedule II drugs, like morphine, have high potential but are acceptable for medical use under strict regulation. Schedule III to V drugs progressively decrease in abuse potential and control. This classification impacts clinical practice by determining prescribing privileges, refill limitations, and storage requirements, influencing both access and compliance. Effective management involves balancing therapeutic benefits with the risk of abuse and dependency .
The first-pass effect refers to the metabolism of a drug within the liver and gut wall immediately after it is absorbed and before it reaches systemic circulation. This process significantly reduces the bioavailability of certain medications when administered orally. Consequently, the choice of administration route is influenced by the need to bypass this effect to achieve adequate blood concentration. Alternatives such as intravenous, sublingual, or transdermal routes allow the drug to circumvent the liver initially, enhancing drug efficacy as they deliver more active drug into circulation without initial deactivation by the liver .